Iron Horse Wealth Management, LLC Lumos Pharma, Inc. Transaction History

Iron Horse Wealth Management, LLC

Previous 0 NaN%

Previous $0 NaN%

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share
Q2 2024 Jul 22, 2024	BUY	$2.19 - $3.04 $0 - $0
Q1 2024 Apr 17, 2024	BUY	$2.64 - $3.22 $0 - $0
Q3 2023 Oct 18, 2023	BUY	$2.63 - $3.49 $0 - $0
Q2 2023 Aug 01, 2023	BUY	$3.01 - $4.38 $0 - $0
Q1 2023 May 01, 2023	BUY	$3.16 - $4.0 $0 - $0
Q4 2022 Jan 19, 2023	BUY	$3.05 - $9.52 $0 - $0
Q2 2022 Aug 04, 2022	BUY	$6.68 - $9.39 $0 - $0
Q1 2022 Apr 11, 2022	BUY	$6.58 - $10.09 $0 - $0
Q4 2021 Jan 19, 2022	BUY	$6.84 - $10.04 $0 - $0
Q3 2021 Oct 06, 2021	BUY	$7.36 - $11.36 $0 - $0
Q2 2021 Jul 23, 2021	BUY	$9.75 - $13.44 $0 - $0
Q1 2021 Apr 13, 2021	BUY	$11.58 - $31.11 $0 - $0
Q4 2020 Jan 14, 2021	BUY	$13.61 - $35.91 $0 - $0

2.19M

Ticker LUMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,396,070
Market Cap $29.8M
Description
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...

Get notified when there are updates to the investment portfolio of Iron Horse Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Iron Horse Wealth Management, LLC with notifications on news.